By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon
A medical device called an amnioscope is used to look at the amniotic fluid during pregnancy. It resembles a narrow, illuminated tube and has a camera or magnifying lens connected to one end.
Through the cervix, the vagina, and finally into the amniotic sac surrounding the foetus, the amnioscope is inserted. You can check the amniotic fluid for meconium (foetal waste material) by looking at its colour, transparency, and consistency. The amnioscope can also be used to take an amniotic fluid sample for further analysis.
Because of advancements in ultrasound technology, which can offer a non-invasive technique to monitor the foetus and assess the amniotic fluid, the amnioscope is now rarely used. However, an amnioscope may still be used as a diagnostic tool in some situations, such as when there is concern about infection or other complications.
The Global Amnioscope Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Extracellular vesicle technology pioneer Direct Biologics, LLC, has introduced AmnioWrap placental-based sheet allografts for use in clinical settings.
A tri-layer, one-of-a-kind graft called AmnioWrap is designed for use in both acute and chronic wounds. A collagen extracellular matrix and a variety of regulatory proteins, including as growth factors, cytokines, and chemokines, which are known to be essential for tissue regeneration and repair, are present in the allograft.
A single-layer amnion allograft with the proper size for ocular applications is called AmnioWrapTM. AmnioWrap allografts provide the essential elements present in human placental tissues, such as an intact extracellular matrix (ECM), growth factors, and cytokines, and act as a protective covering when applied over the wound bed or surgery site.
AmnioWrap is a human amniotic/chorionic membrane allograft that has been dehydrated and sterilised and is designed for homologous usage in the replacement, reconstruction, or augmentation of human tissue.
It includes important elements present in human placental tissues, such as an intact extracellular matrix (ECM), cytokines, and controllable growth hormones. AmnioWrap has been used topically for surgical applications, wounds, burns, soft tissue injuries, and over tendons and ligaments. It is simple to use and handle.
